Top Research Reports For 9th November, 2016
Zacks Investment Research | Nov 09, 2016 04:01AM ET
Wednesday, November 9 2016
Today's Research Daily features new research reports on 16 major stocks, including Chevron (NYSE:CVX), Glaxo (GSK) and Aflac (AFL).
Chevron’s shares have gained more than 19% year-to-date. The analyst emphasizes that the company’s current oil and gas development project pipeline is among the best in the industry, boasting large, multi-year projects. Also, Chevron has been able to boost returns and remain competitive by embarking on aggressive cost reduction initiatives, exiting unprofitable markets and streamlining the organization.
Owing to these positives, the company has been able to report better-than-expected earnings in the third quarter. However, due to commodity price rout, Chevron’s upstream division has been able to extract less value for their products. (You can .)
Glaxo’s shares have struggled recently. Glaxo’s third-quarter 2016 results were impressive with the company beating estimates on all fronts. The analyst likes Glaxo’s diversified base and presence in different geographical areas as well as its efforts to develop its pipeline.
The performance of new products as well as those acquired from Novartis is also encouraging. These should help support revenues and ease the impact of the loss of Advair sales. However, challenges remain in the form of increasing competition, genericization and pricing pressure, which will continue to impact the company’s performance. (You can )
Aflac’s shares have increased by more than 8% year-to-date. Aflac’s third quarter earnings exceeded expectations and grew year over year. The analyst likes the way in which company is trying to differentiate itself from its rivals by paying claims in one day through a program named “One Day Pay.” Aflac’s strong capital position enables it to buy back shares and increase dividend payouts at regular intervals.
Efforts to increase agent productivity also will drive long-term growth. However, Aflac’s top line remains exposed to a challenging operating environment, primarily in Japan. (You can .)
Other noteworthy reports we are featuring today include Analog Devices (ADI), Novo Nordisk (CO:NOVOb) (NVO) and MGM Resorts (MGM).
Confidential: Best Trades from Zacks Research
Would you like to see a hand-picked "all-star" selection of investment ideas from the man who heads up Zacks' trading and investing services? Steve Reitmeister knows when key trades are about to be triggered and which of our experts has the hottest hand. He is now prepared to pass them along to you. From 220 Zacks Rank #1 Strong Buys, this Special tabs 7 for immediate breakout. Click to access these private picks>>
Get The News You Want
Mark Vickery
Senior Editor
Note: If you want an email notification each time Sheraz publishes a new article, please >>>
Today's Must Read/h6
Featured Reports/h6
The Zacks analyst believes that strong performance of drugs like Victoza, Tresiba and Saxenda should continue driving sales in future quarters.
The covering analyst believes that TELUS is actively pursuing new deals and alliances and aims to consolidate its foothold in the Internet of Things (IoT) market.
Stanley Black & Decker (NYSE:SWK) has solid long-term growth potential and it beat the earnings estimate for third-quarter 2016. It raised its earnings guidance for 2016 despite headwind risks in the near term.
The Zacks analyst thinks stabilization in end markets and savings from realignment actions bode well for growth.
The covering analyst believes that Analog Devices' strength in the industrial, auto and communication markets is largely offset by significant weakness in the consumer business.
The Zacks analyst remains optimistic as Fifth Third recorded higher revenues and sustained loan and deposit growth in Q3.
The covering analyst believes Ventas is likely to benefit from efforts to curb skilled nursing facilities business.
The Zacks analyst believes that strong performance of drugs like Victoza, Tresiba and Saxenda should continue driving sales in future quarters.
The covering analyst believes that TELUS is actively pursuing new deals and alliances and aims to consolidate its foothold in the Internet of Things (IoT) market.
Stanley Black & Decker (NYSE:SWK) has solid long-term growth potential and it beat the earnings estimate for third-quarter 2016. It raised its earnings guidance for 2016 despite headwind risks in the near term.
The Zacks analyst thinks stabilization in end markets and savings from realignment actions bode well for growth.
The covering analyst believes that Analog Devices' strength in the industrial, auto and communication markets is largely offset by significant weakness in the consumer business.
The Zacks analyst remains optimistic as Fifth Third recorded higher revenues and sustained loan and deposit growth in Q3.
The covering analyst believes Ventas is likely to benefit from efforts to curb skilled nursing facilities business.
New Upgrades/h6
The Zacks analyst is upbeat about MGM Resorts post its Q3 earnings results. Strong portfolio, focus on non-gaming actions, with improving economy and budding tourism in Las Vegas should drive growth.
The covering analyst believes that Xcel Energy's future performance is likely to improve with improving economic conditions across its service territories.
Ingersoll reported strong 3Q16 results with year-over-year increase in both earnings and revenues that beat the respective Zacks Consensus Estimates.
The Zacks analyst is upbeat about MGM Resorts post its Q3 earnings results. Strong portfolio, focus on non-gaming actions, with improving economy and budding tourism in Las Vegas should drive growth.
The covering analyst believes that Xcel Energy's future performance is likely to improve with improving economic conditions across its service territories.
Ingersoll reported strong 3Q16 results with year-over-year increase in both earnings and revenues that beat the respective Zacks Consensus Estimates.
New Downgrades/h6
Tepid third quarter revenue guidance makes the Zacks analyst increasingly cautious about its near-term performance.
The covering analyst thinks earnings dilution led by high disposition activity, tenant bankruptcy and competition from other players are causes of concern.
Economic uncertainties in Brazil are negatively impacting Navistar's results. Weak delivery guidance for the U.S. and Canada and lower revenues guidance for the year also pose concerns.
Tepid third quarter revenue guidance makes the Zacks analyst increasingly cautious about its near-term performance.
The covering analyst thinks earnings dilution led by high disposition activity, tenant bankruptcy and competition from other players are causes of concern.
Economic uncertainties in Brazil are negatively impacting Navistar's results. Weak delivery guidance for the U.S. and Canada and lower revenues guidance for the year also pose concerns.
Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.